Clinical Trials in San Francisco

Showing 9721-9740 of 12,991 trials

A Novel Method to Determine HIV Incidence Among Youth

NCT00103883

Identifying young people with early HIV-1 infection is important for increasing linkage to care, for behavioral counseling, and for enrolling individuals into programs that can provide effective interventions to disease progression and improve outcome. This study will develop and evaluate a saliva-based sensitive/less sensitive (S/LS) assay for differentiating persons with recent HIV-1 infection (less than 133 days) from those with established HIV-1 infection.

HIV Infection

University of North Carolina, Chapel Hill440 participantsStarted Feb 2003

Los Angeles, California, United States • San Diego, California, United States • San Francisco, California, United States +12 more locations

COMPLETEDPhase 2< 1 mile

Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients

NCT01436500

A study of ifetroban in the treatment of hepatorenal syndrome (HRS) in hospitalized adult patients to assess the safety and pharmacokinetics of 3 days of intravenous ifetroban.

Hepatorenal Syndrome

Cumberland Pharmaceuticals55 participantsStarted Oct 2011

Phoenix, Arizona, United States • La Jolla, California, United States • San Francisco, California, United States +9 more locations

A Novel Method to Determine HIV Incidence Among Youth

Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients

Find Trials by Condition in San Francisco

Identifying Undiagnosed Asymptomatic HIV Infection in Hispanic/Latino Adolescents and Young Adults

Treatment De-Intensification and Residual HIV-1 in Youth

HIV Treatment-Readiness Measure (HTRM) Validation

C2P Mobilization Intervention (Pilot)

CDC-ATN Linkage Evaluation

PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir

A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes

A Phase 2 Study of Pertuzumab and Erlotinib for Refractory Pancreatic Adenocarcinoma

AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN

Naltrexone/Bupropion Cardiovascular Outcomes Study

Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.

Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes

Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

EPO906 in Carcinoid and Other Neuroendocrine Tumors